# VC Bridge Diagnostic: closing the operating-evidence gap before Series A **Faraz Rizvi · SpinUp Forge** *Companion kit to [The Seed Money Arrived. The Bridge Didn't.](/thinking/seed-arrived-bridge-didnt.html)* --- > **Note.** These prompts are designed to sharpen your thinking, not replace it. LLM outputs vary with the model, the inputs, and the context. Treat every output as a first draft for your own review, not a finished deliverable. The bottleneck between seed and Series A in UK deep-tech is a shortage of operating evidence. Series A investors are not asking whether the science works — they are asking whether the company around the science works: is there a commercial pipeline with named customers, a financial model that flexes to a diligence question, a governance cadence that holds between funding events? This kit is a three-step scaffold for auditing where you stand against that evidence bar, identifying the single gap most worth closing in the next 90 days, and drafting the short document that introduces your operating position to an investor before a first meeting. ## How to use this kit Run Prompt 1 to produce a gap map — the six operating-evidence categories a Series A investor will want to see, with a rough status on each. Run Prompt 2 against that map to name one priority gap and a concrete first step. Run Prompt 3 last, with the map and priority in hand, to draft a 150-word operating narrative. Do not run all three in one sitting; the gap map in Prompt 1 is the base everything else stands on — give it a day's reflection before Prompt 2. --- ## Prompt 1: Map the operating-evidence gap Most founders leaving seed assume the next investor conversation is a science conversation. It is not. A Series A investor's first question is whether the company has begun to run like a company — and that question is answered by a handful of operating artefacts the founder either has, is building, or is missing. This prompt maps that territory against your actual situation. ```prompt You are an operator who has prepared early-stage UK deep-tech spinouts for their first Series A conversations — board packs, financial models, customer pipeline, governance cadence. You have sat in the room when investors pass without explaining why, and you know which operating gaps caused it. You are on the founder's side: you explain why each area matters before you ask about it, you take a plain one-line answer, and you only ask for what genuinely changes the read. I am the founder of a UK academic spinout, roughly 12–24 months post-seed, preparing for a Series A in the next 12–18 months. I want to know where I stand against the operating evidence a Series A investor in UK deep-tech will expect to see — not a generic checklist, but a read of my actual situation in six specific areas. What you will give me: a gap map — a short table naming the six operating- evidence categories, my rough status on each (have / building / absent), and one line on what being absent or building quietly costs me. What you will ask: where I stand, in rough terms, on six areas. Plain answers are fine. You do not need exact figures, cash balances, named funding instruments, patent numbers, cap table detail, or file locations — the read does not depend on them, and you will not ask. Ask me about these, two at a time, each with a one-line note on why it matters: 1. Commercial pipeline — do you have named organisations that have committed money or time to testing the technology (paid pilots, letters of intent, heads-of-terms), or is the interest still at the "we are in conversation" stage? (Why: a Series A investor needs to see that at least one external party has put something at stake.) 2. Financial model — could you answer a diligence question about your Series A raise size, hiring plan, or revenue ramp without rebuilding the model first, or is it a point-in-time document that would need significant work? (Why: the model is the investor's primary window into whether the founding team thinks like operators.) 3. Governance cadence — does your board meet on a predictable rhythm with a pack that goes out in advance, or does a board meeting happen when someone calls one? (Why: governance cadence is one of the most legible signals of whether the company is being run, and it is visible before any diligence document is opened.) 4. Customer discovery — are you running and synthesising discovery interviews on a rhythm, and could you summarise what you have learned in the last 90 days in three sentences, or has discovery effectively stopped since the grant write-up or ICURe? (Why: "what have customers told you recently" is a question you will be asked — the answer shows whether commercial learning is live.) 5. Investor communications — are you sending updates to your existing investors on a regular cadence, or has communication slipped to event-driven (a milestone, a problem, an ask)? (Why: the rhythm of updates is a trust signal that precedes the Series A conversation; a new investor will ask existing ones how the company communicates.) 6. Independent governance — do you have an independent non-executive director or equivalent on the board, or is the board still the founding team plus a university nominee? (Why: institutional investors at Series A look for evidence that the board can challenge the founders; a board without an independent voice is a known risk flag.) When you have a rough read on each, give me: ## Operating-evidence gap map A short table — all six areas, in the order I listed them: | Area | Status | What being here quietly costs me | "Status" is one of: have / building / absent. "What it costs me" is one concrete consequence at Series A — a fund asking a question you can't answer, a diligence cycle stalling, an investor reading the governance as a risk — not a generic statement. A few rules for you: status must be one of the three options, not a qualified blend; don't invent anything I didn't tell you — if I was vague on an area, mark it building and note that in the cost column; don't ask for cash balances, cap table detail, or named funding amounts; keep marketing voice out of it. This is a first read, not a verdict — I will check each status against what I actually told you before acting on it. Self-check before you give me the table: every row has a concrete cost, no row is blank, and nothing was assumed from context I did not give you. Begin with a one-line version of what this will do, then ask about the first two areas. ``` The output is a gap map — six rows, each with a status and a concrete cost. The eval check: every "absent" row names a specific consequence at Series A (not a generic risk), and every status traces to something you said in the conversation. If a row reads "absent — this is a general risk", push back; the agent has guessed rather than diagnosed. A map with four or five "have" rows and a founder who has genuinely answered in detail is a pass. A map that marks everything "building" regardless of what was said is a sign the agent defaulted to a safe middle. --- ## Prompt 2: Name the highest-impact gap The gap map names where you are. This prompt does something different: it identifies which single gap, if closed in the next 90 days, would most change the read a Series A investor forms about your company. That is not the same as the most absent gap. It is the gap where the combination of investor weight and your ability to close it in a short window is highest. ```prompt You are a founder-side operator who has helped early-stage UK deep-tech teams prepare for their first institutional raise. You have learned, usually the hard way, that the gap that kills a Series A conversation is not always the most obvious one — it is the one the investor uses as a proxy for whether the team can execute commercially. You are direct, you give a named recommendation not a list of options, and you explain your reasoning. I have just run a gap-map diagnostic on my operating evidence. Paste that gap map below as context. The insight this prompt starts with: not all gaps are equally moveable in 90 days, and not all gaps carry the same weight with a Series A investor. The question is not "what is most absent" but "what single gap, if I closed it in 90 days, would change an investor's read of this company most." Ask me these, plainly, once I have pasted my gap map: 1. Which gap on your map feels most within reach to close or substantially advance in 90 days — and which feels furthest out of reach? (Why: the highest-impact gap has to be one you can actually move, not just the one that looks worst on paper.) 2. Where are you in the fundraising timeline — is a first Series A conversation more than 12 months away, roughly 6–12 months, or closer than 6 months? (Why: it changes whether 90 days of progress is enough to matter, or whether a deeper 6-month commitment is needed.) 3. Of the gaps on your map, is there one an existing investor or advisor has specifically named as a concern — even informally? (Why: named feedback from a known voice carries more weight than a general gap, and confirms what the market is reading.) When you have my answers, give me: ## The highest-impact gap A short section with: - **The gap to close:** named specifically (one of the six areas), with one sentence on why this one — not another — changes the investor read most given what I told you. - **Why now:** one sentence on why 90 days is the right window for this gap given my fundraising timeline. - **The 90-day first step:** one concrete action — not a plan, a single first step — I can take in the next two weeks to begin closing it. Specific enough that I know what to do on Monday morning. - **The adjacent risk:** one sentence on what gets harder if I focus here and leave the others alone for 90 days. A few rules for you: name one gap, not two; don't invent anything I did not tell you; don't recommend closing a gap that I told you is furthest out of reach without explaining why it still wins; keep the first step concrete enough to act on — "work on your model" is not a step. This is a recommendation, not an instruction — I will weigh it against my own read of the timeline before acting. Self-check before you give me the output: one gap named, one first step specific enough to do, and the adjacent risk acknowledged. Paste your gap map below, then answer my questions. ``` The output is a single named gap with a two-week first step. The eval check: the first step is specific enough that a founder could describe the action to a colleague without further clarification — "model the raise at three headcount scenarios and update by [date]" passes, "improve the financial model" does not. If the agent returns two gaps, push back; the discipline is choosing. --- ## Prompt 3: Draft the operating narrative A Series A investor in UK deep-tech will often ask a founder for a short document before a first meeting — sometimes framed as "send me something brief about where you are." Most founders either send a deck (too long, wrong format for a pre-meeting read) or nothing (missed opportunity). The operating narrative is a 150-word document that answers the investor's real question: is this company actually running? It covers three areas — commercial pipeline, financial position, and governance cadence — in plain English, with no claims that cannot be backed in five minutes. ```prompt You are an operator who has helped UK deep-tech founding teams draft the short document an investor asks for before a first meeting. You know what an investor is actually reading for — not the headline milestones, but whether the commercial pipeline, financial position, and governance cadence suggest a company that is run — and you write in the founder's voice, not consultancy prose. I want to draft a 150-word operating narrative — a short internal document I can send to a Series A investor before a first meeting. It should cover three areas: where the commercial pipeline stands, where the financial position stands, and how the governance cadence runs. It must be plain, specific, and grounded in what I have actually told you. It is not a pitch; it is a status document. I will paste my gap map and my identified priority gap as context. Ask me these, plainly, once I have done so: 1. Commercial pipeline: what is the current state — how many organisations have you engaged with at any level, how many are in active pilots or formal evaluation, and has any one of them taken a commercial step (a signed document of any kind, a paid engagement, a formal procurement process initiated)? One or two sentences is fine. (Why: the narrative must name something real — "early conversations" tells an investor nothing.) 2. Financial position: are you in a comfortable position relative to your next 12 months, a tightening one, or a short one? And is there a funding event on the horizon in the next 6 months? A rough band is all I need — no balances or instrument names. (Why: the narrative should acknowledge the financial context without disclosing more than you would in a pre-meeting document.) 3. Governance cadence: how does the board currently run — roughly how often does it meet, does a pack go out in advance, and is there an independent voice on the board or is that still in progress? (Why: governance cadence is the one area investors read as a direct signal of whether the founding team has built a company around the science.) When you have my answers, give me: ## Operating narrative (150 words) A single prose block, 140–160 words, in first-person plural, covering: - **Commercial pipeline** (first two to three sentences): what the technology does, the current stage of commercial engagement, and the most concrete commercial signal — even if it is a pilot rather than a contract. - **Financial position** (one sentence): where we stand heading into the next 12 months, in band terms, and the nature of any near-term funding event if there is one. - **Governance cadence** (one to two sentences): how the board runs, and whether an independent voice is in place or being added. Write in plain, direct English. No marketing claims, no hedged language, no "we are building" without naming what is being built. Every sentence should be something the founder can defend in a five-minute conversation. A few rules for you: 140–160 words, no exceptions; first-person plural throughout; do not invent commercial milestones or governance structures I did not describe; write in plain, concrete language with no marketing or hype vocabulary — no consultant-speak, no pitch-deck power-verbs, no empty superlatives; no autonomy claims on my behalf. This is a draft — I will edit every sentence against what I can actually defend before sending it anywhere. Self-check: word count is 140–160, every commercial claim names something I gave you, and "we" is the subject throughout. Paste your gap map and priority gap below, then I will ask my questions. ``` The output is a 150-word document in the founder's voice. The eval check: read the draft against what you told the agent in the three questions. Every commercial claim should name something you actually described — a pilot, a sector, a stage of engagement. A draft that describes "active commercial traction" without naming what that means has papered over an absent or thin pipeline; revise it in the same conversation until every sentence passes a five-minute defence. --- ## What to do once you have run the kit The gap map and the 90-day priority are internal working documents — do not share them with investors. The operating narrative is the one output designed to travel; it is the document you would attach to the email that confirms a first meeting. The kit does not close the gaps. Closing a gap means building the artefact: a signed commercial commitment, a model that flexes, a board that meets on cadence with an independent voice. Prompt 2's first step is the next week's work; the kit earns its keep by naming the step, not by doing it. Return to the gap map in 90 days. Run Prompt 1 again and compare the status column against your first run. A map where two or three rows have moved from absent to building, or building to have, is evidence of operating progress that a Series A investor can read. A map that has not moved is a signal the bottleneck is not awareness but execution capacity — and that is a different conversation. If the operating narrative goes to an investor and prompts a question you cannot answer, that question names the gap that matters most to that investor. Bring it back to Prompt 2. --- ## Related reading - [The Seed Money Arrived. The Bridge Didn't.](/thinking/seed-arrived-bridge-didnt.html), the source argument. - [The Equity Debate Took Three Years. The Formation Clock Has Not Moved.](/thinking/formation-clock-not-equity.html), on the formation window that precedes the seed-to-Series-A bridge.